Largest biotech by net assets

Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.

ImmunityBio has the lowest figure of the 24 biotech ranked by net assets, at -CHF 421.9M, followed by Halozyme Therapeutics (CHF 41.1M) and Kodiak Sciences (CHF 132.7M). Figures as of 18 Nov 2026, 15:49 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
24
Lowest
ImmunityBio-CHF 421.9M
Median
CHF 1.7B
Combined market value
CHF 705.5B
Countries
5

Market values as of .

Largest biotech by net assets
#CompanyNet assets ↑Market capPriceToday1 yearPrice, 30 daysCountry
1ImmunityBioIBRX · Health Care-CHF 421.9MCHF 5.9BCHF 5.52 4.63% up 193% up United States
2Halozyme TherapeuticsHALO · Health CareCHF 41.1MCHF 9.3BCHF 81.45 0.68% up 37% up United States
3Kodiak SciencesKOD · Health CareCHF 132.7MCHF 5.4BCHF 81.90 0.37% up 396% up United States
4Adaptive BiotechnologiesADPT · Health CareCHF 184.4MCHF 3.9BCHF 23.97 0.21% down 88% up United States
5Scholar Rock HoldingSRRK · Health CareCHF 206.9MCHF 4.8BCHF 39.30 3.42% up 14% up United States
6Twist BioscienceTWST · Health CareCHF 398.7MCHF 6.5BCHF 95.69 1.36% up 340% up United States
7CG OncologyCGON · Health CareCHF 634.4MCHF 6BCHF 67.37 1.24% up 85% up United States
8ImmunovantIMVT · Health CareCHF 718.7MCHF 5.8BCHF 28.24 0.87% up 43% up United States
9Krystal BiotechKRYS · Health CareCHF 1BCHF 7.6BCHF 258.05 2.54% up 46% up United States
10Kymera TherapeuticsKYMR · Health CareCHF 1.3BCHF 8.7BCHF 102.09 0.34% down 87% up United States
11Revolution MedicinesRVMD · Health CareCHF 1.4BCHF 29BCHF 134.11 2.21% down 131% up United States
12CRISPR TherapeuticsCRSP · Health CareCHF 1.6BCHF 3.4BCHF 34.72 2.59% up 21% down Switzerland
13RepligenRGEN · Health CareCHF 1.8BCHF 9.2BCHF 143.56 5.01% up 5% up United States
14Bio-TechneTECH · Health CareCHF 1.8BCHF 9.6BCHF 61.29 0.10% up 26% up United States
15ExelixisEXEL · Health CareCHF 1.8BCHF 14.1BCHF 57.80 0.10% up 63% up United States
16VaxcytePCVX · Health CareCHF 2.3BCHF 7.7BCHF 48.89 2.37% down 22% up United States
17Neurocrine BiosciencesNBIX · Health CareCHF 2.7BCHF 13.8BCHF 136.71 2.26% down 20% up United States
18QiagenQGEN · Health CareCHF 3.2BCHF 8.6BCHF 41.78 0.38% down 12% up Netherlands
19argenxARGX · Health CareCHF 6.2BCHF 50.3BCHF 799.74 0.13% up 4% up Belgium
20ModernaMRNA · Health CareCHF 7.3BCHF 68.2BCHF 168.49 3.35% down 755% up United States
21AmgenAMGN · Health CareCHF 7.3BCHF 203.4BCHF 376.02 2.59% down 34% up United States
22BiogenBIIB · Health CareCHF 15.4BCHF 31BCHF 209.96 0.68% down 49% up United States
23BioNTechBNTX · Health CareCHF 18BCHF 17.5BCHF 70.65 1.24% down 16% down Germany
24Gilead SciencesGILD · Health CareCHF 19.1BCHF 175.6BCHF 141.61 1.34% down 33% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 0.8430 CHF).

Questions and answers

Which biotech have the lowest net assets?

ImmunityBio (-CHF 421.9M), Halozyme Therapeutics (CHF 41.1M) and Kodiak Sciences (CHF 132.7M) have the lowest net assets of the 24 biotech ranked here as of 18 Nov 2026, 15:49 UTC.

How many biotech are in this ranking?

24 are ranked by net assets.

What are these biotech worth together?

The 24 biotech ranked by net assets have a combined market value of CHF 705.5B as of 18 Nov 2026, 15:49 UTC.

What does ranking by net assets measure?

Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.

Cite this page

Funkfolio, “Largest biotech by net assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=net-assets

Underlying data: Yahoo Finance; SEC EDGAR.